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Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312 S71Purpose: Alkaptonuria (AKU) is an ultra rare autosomal recessive
disorder resulting from a deﬁciency of the enzyme homogentisate 1, 2-
dioxygenase (Hgd), and is characterised by accumulation of homoge-
ntisic acid (HGA) in plasma and marked excretion in urine. HGA is
deposited as a dark pigment in collagenous tissues (ochronosis), prin-
cipally the cartilages of loaded joints, resulting in early onset, devas-
tating osteoarthropathy. Studying the extreme AKU phenotype is
helping to increase our understanding of more common osteoarthritis
(OA). Previous studies have suggested that Hgd-/- mice do not develop
ochronosis. Our aim was to make a comprehensive survey of Hgd-/-
mice, to identify if ochronosis was present, and to determine the
pathogenesis.
Methods: Hgd-/- mice were culled between 6 and 65 weeks and
samples wax-embedded in the coronal plane to enable simultaneous
evaluation of both medial and lateral tibio-femoral articulations, as
recommended by the OARSI histopathology initiative. Histological
evaluation was performed with Schmorl's reagent and haematoxylin-
eosin staining.
Results: We report the ﬁrst observation of ochronosis in Hgd-/- mice.
Using Schmorl's reagent we identiﬁed the earliest stages of ochronosis
and were able to follow the pathogenesis of the disease throughout
their lifespan. Pigmentation was initially identiﬁed at 16 weeks, local-
ised to the pericellular matrix of individual chondrocytes in calciﬁed
articular cartilage. Pigmentation was then observed progressing to the
cellular compartment of an increasing number of chondrocytes
throughout the calciﬁed articular cartilage by age 40 weeks. After 65
weeks, pigmentation of chondrocytes and their pericellular matrix was
observed throughout the calciﬁed articular cartilage of the entire tibio-
femoral joint. Although pigmentation was extensive at this stage, some
viable chondrocytes remained as well as those still in the early phases of
pigmentation. In some instances both viable and pyknotic chondrocytes
were observed in the same isogenous group.Figure 1. Progression of ochronosis in Hgd-/- mice. Stages of pigmentation show (1)
a viable unstained chondrocyte, (2) pericellular pigmentation and (3) a fully pig-
mented pyknotic chondrocyte. Bar ¼ 20mm.Conclusions: The observation of ochronosis in Hgd-/- mice is an
important step in understanding the pathogenesis of AKU. By identifying
the earliest stage of ochronosis, which is synonymous to that seen in
human AKU, we can investigate the initiation and progression of
pigmentation. Initial pigmentation in the pericellular matrix suggests
a compositional or organisational change occurs in the matrix allowing
deposition of HGA, which binds to collagen ﬁbres starting the process of
ochronosis. Progression of ochronosis to the cell is consistent with
ochronosis in humans, and is probably due to the increasing amount of
HGA being deposited following the initial transformation of its peri-
cellular environment. The very early ochronosis and subsequent
progression observed in this study shows that AKU, thoughpresenting in
humans as a painful syndrome in mid-life, is the result of a lifelong
pathological process. Using Hgd-/- mice, we can now investigate
biochemical andpathological changes associatedwithAKU that progressto joint degeneration. Furthermore, as AKU is associated with the onset
of prematureOA,we canuse themodel to identify the initiating events in
OA by studying the role of subchondral bone and calciﬁed cartilage: both
play an important role in the pathology of AKU and OA.
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MOLECULAR PREDICTORS OF HAND STRENGTH
D. Thompson, K. Huffman, G. McDaniel, J. Bain, R. Stevens,
C. Newgard, V. Kraus. Duke Univ., Durham, NC, USA
Purpose Grip strength predicts disability and mortality, yet few
biomarkers of hand strength have been identiﬁed. We surveyed a wide
array of serum cytokines, metabolites and joint tissue markers to
identify novel independent predictors of grip and pinch strength.
Methods Subjects were originally recruited for a longitudinal study of
radiographic knee osteoarthritis (OA) progression. At three year follow
up, measurement of grip strength (Jamar Hydraulic Hand Dynamom-
eter) and key pinch strength (Jamar Hydraulic Pinch Gauge) were per-
formed twice on each hand, and the greatest value was used for
analyses. To control for hand OA, bony enlargements of the four distal
and ﬁve proximal interphalangeal joints, the ﬁve metacarpophalangeal
joints, and the carpometacarpal joint were summed (range 0-15) for the
stronger hand. Blood (2 hour postprandial) was collected, and serum
stored at -80oC. Cytokines and inﬂammatory markers (adiponectin;
brain-derived neurotrophic factor; d dimer; granulocyte colony stim-
ulating factor; interleukins 1, 6, and 8; regulated upon activation normal
T cell expressed and secreted; tumor necrosis factor alpha, TNFa; TNFa
receptors 1 and 2; TNF related apoptosis-inducing ligand, TRAIL; soluble
vascular cell adhesion molecule 1; and vascular endothelial growth
factor) and joint tissue markers (C2C; CPII; cartilage oligomeric matrix
protein; hyaluronic acid, HA; and matrix metalloproteinase 3) were
measured by immunoassay. Acylcarnitines (ACs, n¼45) and amino acids
(AAs, n¼15) were measured using a targeted mass-spectrometry plat-
form. Additional metabolites (glucose; a-hydroxybutyrate; total
ketones; lactate; non-esteriﬁed fatty acids; and uric acid) were
measured with a Hitachi 911 analyzer. Computed variables included
global arginine bio-availability ratio (GABR, arginine/(ornithine +
citrulline) and C2C:CPII. All variables except age, HA, MCP-1, and TRAIL
were log-transformed because of non-normal distributions. Principal
components analysis, with varimax rotation, reduced separately the
AAs and ACs each to a 1 factor solution. Multivariable correlations were
performed between grip or pinch strength and serum markers,
controlling for age, sex, and height. Candidate predictors of grip or
pinch strength were analyzed by linear regression, controlling for age,
sex, height and sum of bony enlargements followed by multivariable
modeling of signiﬁcant variables by stepwise selection (p<0.05).
Results The subject population (n¼138) was 73% female, mean (SD) age
of 65.8 (11.5) years, BMI 31.4(6.9) kg/m2, grip strength of 27.4 (10.0) kg,
and pinch strength of 5.9 (1.9) kg. Grip and pinch strength correlated
with age, sex, and height (p<0.05), but not weight, BMI, or sum of bony
enlargements. Multivariable modeling identiﬁed sex, age, height, C2C,
and the AA Factor as signiﬁcant, independent predictors of grip
strength; the model predicted 55% of the variability of grip strength and
was signiﬁcant at p<0.0001. For pinch strength, multivariable modeling
identiﬁed sex, age, height, the ratio C2C:CPII, GABR, and the AC Factor as
signiﬁcant, independent predictors; the model predicted 49% of the
variability of pinch strength and was signiﬁcant at p<0.0001.
Conclusion This exploratory analysis identiﬁed several novel, inde-
pendent predictors of both grip and pinch strength. As seen previously,
age, sex, and height were the strongest predictors of hand strength. AA
factor predicted grip strength, perhaps reﬂecting sarcopenia status. The
association of C2C or the ratio of C2C and CPII, markers of collagen
breakdown and synthesis, respectively, with grip and pinch strength
suggests the involvement of joint tissue turnover with hand function.
The signiﬁcant associations of GABR and the AC factor implicate
metabolic pathways in pinch strength.
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HAND OSTEOARTHRITIS IS ASSOCIATED WITH INCREASED TYPE II
COLLAGEN DEGRADATION IN WOMEN: THE OFELY STUDY
J.-C. Rousseau y, E. Sornay-Rendu y, C. Bertholon y, P. Garnero y,z, R.
Chapurlat y. y INSERM Unit 1033, Lyon, France; zCisbio bioassays,
Codolet, France
Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312S72Purpose: Hand osteoarthritis (OA) is one of the most common locali-
zation of OA, affecting predominantly women. Patients with knee, hip
or spine OA exhibit increased cartilage type II collagen degradation as
detected by the urinary excretion of C-terminal crosslinking telopeptide
of type II collagen (CTX-II), but data on hand OA are lacking. The aim of
this study was to investigate the relationship between urinary CTX-II
and hand OA in women.
Subjects and Methods: We investigated 590 women from the OFELY
population-based study (mean age: 61.8 years  10.2) including 475
postmenopausal women. Clinical hand OAwas deﬁned according to the
ACR criteria (Altman et al, 1990) slightly modiﬁed (without functional
complains). At the same time of hand OA evaluation, knee and spine OA
were assessed by radiographs and self-reported hip OA was recorded.
Levels of urinary CTX-II measured by ELISA (Urine CartiLaps, IDS) in
the 186 women with hand OA (mean age: 67.2 years  8.4) were
compared to those of the 404 other women without hand OA (mean
age: 59.4 years  10.1). All analyses were adjusted for age and
concomitant knee, hip or spine OA.
Results: Urinary CTX-II levels were signiﬁcantly increased in women
with hand OA (+ 45% vs controls, p¼ 0.001) after adjustment for age and
for knee, spine and hip OA). When urinary CTX-II concentrations were
considered in quartiles, subjects with levels in the highest quartile had
an increased risk of presenting with hand OA, with an odds-ratio of 2.06
(95% CI: 1.3-3.2; p ¼ 0.002) after adjustment for OA at the other
anatomical sites.
Conclusion: Hand OA is characterized by increased type II collagen
degradation. Urinary CTX-II could be a useful biomarker for the clinical
investigation of hand OA.118
TNF-a IS ELEVATED IN SYNOVIAL FLUID OF PATIENTS WITH AN
ANTERIOR CRUCIATE LIGAMENT RUPTURE 5 YEARS AFTER THE
INJURY. PRO-INFLAMMATORY CYTOKINES IN SYNOVIAL FLUID AND
SERUM – A PROSPECTIVE LONGITUDINAL STUDY
M. Hansson y, S. Larsson y, R. Frobell y, L.S. Lohmander y,z,
A. Struglics y. y Lund Univ., Clinical Sci. Lund, Lund, Sweden; zRes. Unit for
Musculoskeletal Function and Physiotherapy, and Dept.s of Orthopaedics
and Traumatology, Univ. of Southern Denmark, Odense, Denmark
Purpose: Trauma induced cytokine response in knee injuries may play
a role in the development of osteoarthritis (OA) since knee injuries areTable 1
Cytokine concentrations (pg/ml) in SF and serum expressed as medians (25th–75th percen
at different time. Half LLOQ values: IL-10, 1.0; IL-6, 0.3; IFN-g, 0.6.
Groups n IL-8
Conc. P-values
Ref 20 13.8 (9.6-83.2) -
23 9.0 (5.8-14.9) -
Baseline 51 89.2 (47.8-189.7) <0.001
119 5.8 (4.5-7.6) <0.001
16 weeks 50 29.4 (16.2-77.1) 0.091
64 6.1 (4.4-10.9) 0.067
30 weeks 47 23.4 (16.2-37.9) 0.279
63 6.5 (4.8-9.2) 0.041
52 weeks 47 20.1 (10.9-37.1) 0.722
63 6.3 (4.6-8.9) 0.018
104 weeks 81 15.8 (11.6-26.2) 0.878
118 5.5 (4.4-7.4) <0.001
260 weeks 64 10.6 (7.4-14.4) 0.046
114 5.8 (4.6-7.5) 0.002
Groups n IL-6
Conc.
Ref 20 0.7 (0.3-8.2)
Baseline 51 1271.1 (321.0-3614.7)
16 weeks 50 11.2 (3.3-33.1)
30 weeks 47 3.2 (0.6-16.5)
52 weeks 47 1.3 (0.3-5.7)
104 weeks 81 1.0 (0.3-4.0)
260 weeks 64 0.7 (0.3-2.5)often a gateway to OA. Cytokines regulate responses to infection,
inﬂammation and trauma, attract leucocytes to the affected tissue, and
are involved in tissue destructionmediated bymatrix metalloproteases.
Blocking of cytokines (e.g. TNF-a) has been successful in the treatment
of patients with rheumatoid arthritis. As part of a longitudinal study
(KANON study), wherewe aim to analyze different outcomes in patients
suffering from ruptured anterior cruciate ligaments (ACL), we here
report the pro-inﬂammatory cytokine levels in synovial ﬂuid (SF) and
serum at different times after injury.
Methods: SF and serum was collected from ACL injured patients
(n¼121) 0-3 weeks (baseline), at 16, 30, 52, 104 and 260 weeks after the
injury. Mean age of the included patients was 26 years (range 18-35)
and 74% were male. Samples from knee healthy subjects (reference
group n¼23) matched for age were included. Pro-inﬂammatory cyto-
kines (IL-1b, IL-6, IL-8, IL-10, IL-12 p70, IFN-g, and TNF-a) were analyzed
using the Human Pro-inﬂammatory 7-plex Ultra-Sensitive Kit (Meso
Scale Discovery) according to manufacturers instruction. Recovery and
dilution linearity tests were performed on randomly selected SF
samples. Values below lower limit of quantiﬁcation (LLOQ) were
assigned half the LLOQ value for each cytokine. Concentrations were not
normally distributed and thus between group differences were
analyzed using the Mann-Whitney U-test and correlations using
Spearman's rank test (rS).
Results: The serum concentrations of IL-1b, IL-6, IL-12p70 and IFN-g
were below LLOQ for 73-100% of the analyzed samples and were
therefore excluded. IL-10 was detectable in 50% of the samples, while
TNF-a and IL-8 were detectable in all serum samples. Serum concen-
trations of IL-8 were signiﬁcantly lower in the injured group at all time
points, except at 16 weeks, when compared with the reference group
(Table 1).
The SF concentrations of IL-1b and IL-12 p70 were below LLOQ for 59-
100% of the samples and were excluded. Compared to the reference
group, SF concentrations of IL-6, IL-8, IL-10, IFN-g and TNF-a were
signiﬁcantly elevated in the injured group at baseline. IL-6 levels at
baseline were about 1800 times higher compared with the reference
group, thereafter levels decreased, and after 30 weeks and later no
signiﬁcant differences were observed. The SF concentration of TNF-
a was elevated directly after injury and remained signiﬁcantly
elevated over 5 years compared to the reference group (Table 1).
Further, a positive correlation was observed between SF and serum for
IL-8 (rS¼0.156, p¼0.004) and TNF- a (rS¼0.109, p¼0.043)
concentrations.tile range), P-values for group comparisons between references against ACL patients
IL-10 TNF-a
Conc. P-values Conc. P-values
1.0 (1.0-2.4) - 2.2 (1.0-3.6) -
2.2 (1.0-6.5) - 5.9 (4.9-7.3) -
20.1 (8.8-41.1) <0.001 12.4 (9.8-15.2) <0.001
1.0(1.0-3.0) 0.205 6.3 (5.2-7.7) 0.303
2.8 (1.0-4.7) 0.089 5.8 (4.8-7.2) <0.001
2.0 (1.0-2.8) 0.483 6.3 (5.3-7.7) 0.240
1.0 (1.0-2.4) 0,889 4.7 (3.9-6.2) 0.001
1.0 (1.0-3.6) 0.271 6.5 (5.4-7.3) 0.185
1.0 (1.0-2.1) 0.368 4.4 (3.4-5.6) 0.001
1.0 (1.0-2.6) 0.191 6.3 (5.3-6.9) 0.461
1.0 (1.0-2.3) 0.396 4.0 (3.2-4.8) 0.002
1.0 (1.0-2.8) 0.163 6.3 (5.4-7.5) 0.237
1.0 (1.0-1.0) 0.070 3.7 (2.5-4.5) 0.044
2.0 (1.0-3.6) 0.530 6.5 (5.1-8.0) 0.199
IFN-g
P-values Conc. P-values
- 0.6 (0.6-0.6) -
<0.001 8.0 (2.9-28.1) <0.001
0.005 0.6 (0.6-1.4) 0.372
0.209 0.6 (0.6-0.6) 0.387
0.528 0.6 (0.6-0.6) 0.670
0.895 0.6 (0.6-0.6) 0.564
0.588 0.6 (0.6-0.6) 0.446
